Mark Gilreath has served as the President and Chief Executive Officer of EndoChoice since February 2008. Under his leadership, EndoChoice has been recognized by Inc. Magazine as one of the fastest growing companies in the U.S. for 2010, 2011 and 2012.
Prior to EndoChoice, Gilreath joined Given Imaging in 1999 with a small team of entrepreneurs in Israel. He served as President of Given Imaging, Inc. and Chief Marketing Officer, commercializing the revolutionary PillCam™ Video Capsule, transforming a startup with zero revenue to a NASDAQ company achieving $125 million in sales in 2008.
From 1992 to 1999, Mr. Gilreath held a variety of management positions with PENTAX Medical, including Product Manager, Director of Marketing, Area Sales Manager and Director of Business Development.
Before joining PENTAX, from 1989 to 1992, Mr. Gilreath served as an officer in the U.S. Navy. While in Naval Intelligence, Gilreath graduated Summa Cum Laude from the prestigious Defense Language Institute in Monterey, CA.
Mr. Gilreath holds a B.Sc. in Finance from Winthrop University and an MBA from the Fuqua School of Business at Duke University.
Mike Lambert has over 20 years of M&A, accounting and financial management experience within both privately and publically traded enterprises. He joined EndoChoice in early 2011. At EndoChoice, Mr. Lambert is responsible for all aspects of financial management, including treasury, planning and analysis, accounting, and financial reporting, providing guidance to the global organization to meet its financial objectives and allocating resources accordingly. He serves as the primary contact for banking and lending relationships, and reports the company’s results and outlook to investors and other stakeholders.
Prior to EndoChoice, Mr. Lambert served as the Chief Financial Officer for Connecture, Inc., a $25 million private equity-backed provider of enterprise software to health insurance carriers. He led initiatives to improve core business profitability and drove capital raising efforts for business expansion.
From 1999 to 2002, Mr. Lambert served as Vice President of Internal Audit for ChoicePoint, Inc., leading the financial diligence and analysis effort for over 20 M&A transactions in support of the company's aggressive growth strategy. In 2002, Mr. Lambert was promoted into the financial leadership role for the Marketing Services segment of ChoicePoint, a position he held until 2007. Prior to his work at ChoicePoint, Mr. Lambert served as the Manager of Financial Planning for Southern Energy, Inc. He provided critical accounting support and analysis for M&A activity as Southern Company invested over $1 billon in geographic expansion opportunities in the electric utility industry. Mr. Lambert began his career in public accounting, working with Arthur Andersen from 1989 to 1994.
Mr. Lambert holds a B.Sc. in Accounting from Wake Forest University and is a licensed CPA.
Lou Malice has worked in the field of medical device manufacturing, research and development, supply chain, quality and regulatory for more than 20 years. He joined EndoChoice as COO in early 2008. At EndoChoice, Mr. Malice is responsible for ensuring the global manufacturing of quality products at world-class delivery rates. Mr. Malice is also responsible for regulatory compliance and information technology, linking EndoChoice’s global entities.
Prior to EndoChoice, Mr. Malice served as Co-CEO of a successful start up, American Breast Care, LP, which he founded in January 2003, leading the company from green field to $8 million in three years. Prior to his work at American Breast Care, Mr. Malice served as Division President of Coloplast Corporation (a subsidiary of Coloplast AS of Denmark), a $1 billion manufacturer of ostomy, continence, wound care, skin care and breast care products. As head of the $35 million breast care division, Mr. Malice led a group that designed, developed and produced products for the global market leader.
From 1985 to 1993, Mr. Malice was employed by Amoena Corp, rising from Engineering Manager to the position of Vice President of Operations. Under Mr. Malice’s leadership, Amoena grew from a small manufacturer to a large market leader that was acquired by Coloplast for $78 million.
Mr. Malice holds a B.Sc. in Industrial Management from Georgia Institute of Technology.
Doug Ladd has over 25 years of business experience in marketing and brand management in the fields of general surgery, breast care, cardiac surgery and flexible endoscopy. He joined EndoChoice in 2012. At EndoChoice, Mr. Ladd’s responsibilities include defining and launching new products, developing and protecting our EndoChoice brand, delivering clear and consistent communications about our products and brand to the market, gathering and analyzing inputs on market trends and strategic planning on a global basis.
Prior to EndoChoice, Mr. Ladd served as Director of Marketing for World-Wide Franchise Development within Johnson & Johnson. He was responsible for launching new products and business units.
From 2001 to 2002, Mr. Ladd served as the Vice President of Sales and Marketing for AtriCure, Inc. He played a critical role in forming the company, securing the initial rounds of venture capital funding and launching the company’s new technology for the surgical treatment of atrial fibrillation. From 1996 to 2001, Mr. Ladd worked in a variety of marketing roles within Ethicon Endo-Surgery, Inc., a provider of surgical technologies and products. From 1994 to 1996, Mr. Ladd worked in marketing for ChoiceCare, a not-for-profit HMO subsequently acquired by Humana. From 1986 to 1994, Mr. Ladd was with Merrell Dow Pharmaceuticals progressing from sales representative to sales trainer and subsequently to sales manager.
Mr. Ladd holds B.Sc. degrees in Marketing and Organizational Behavior from Miami University and an MBA from Xavier University. Mr. Ladd is also an Adjunct Instructor at the University of Cincinnati’s Lindner College of Business where he teaches international marketing.
Yoram Ashery has 20 years experience in executing broad management and business responsibilities for the healthcare industry. He joined EndoChoice in April 2013. At EndoChoice, Mr. Ashery is responsible for growing the company's business across international markets by expanding the marketing, sales and service organizations, delivering the company's broad portfolio of products and services and unique customer experience while establishing its position as a leader in the international GI markets.
From 2007 to 2013, Mr. Ashery served as the CEO for Aposense Ltd. (TASE: APOS), a clinical stage biopharma and global leader in the development of small molecular drugs that target apoptosis (programmed cell death) for molecular imaging and therapy. As CEO, Mr. Ashery led the company's reorganization from a research and discovery group to a market driven, state-of-the-art drug development firm. Under his leadership, the company more than doubled its drug pipeline, entered multiple partnerships with big pharma and commercial partners and went public on the Tel-Aviv Stock Exchange.
From 2000 to 2006, Mr. Ashery served as Vice President, Business Development for Given Imaging and member of its executive management, with a focus on strategic and international expansion. Before joining Given Imaging, Mr. Ashery was a partner with Zellermayer, Pelossof & Co., one of Israel's premier corporate law firms, where he practiced and led corporate finance, M&A and licensing transactions in the medical technology sector.
Mr. Ashery holds a LL.B (Law) and B.A. Economics cum laude from Tel Aviv University, and serves on the governing board of the Israeli Public Companies Association, as head of the organization’s life-sciences section.
Will Parks has worked in the field of GI devices since 1992. He co-founded EndoChoice with Mark Gilreath in late 2007. At EndoChoice, Mr. Parks is responsible for creating and managing strategic business partnerships around the world, evaluation of new product inventions and identification of portfolio enhancing companies.
Prior to EndoChoice, Mr. Parks successfully led Champion Cart Corporation, which he also co-founded with Mr. Gilreath in 1993. Champion Cart, which grew more than 30% annually in revenues was eventually merged into EndoChoice in October 2007.
From 1992 to 2002, Mr. Parks worked at PENTAX Medical as a Manufacturer's Distributor focused on GI endoscopy video equipment, therapeutic devices, and repair services. In this role, Mr. Parks won several awards for leading two regions from declining sales to significant gains.
Mr. Parks holds a B.Sc. in Marketing and an MBA from Winthrop University.
Gregg Costantino has worked in the field of GI devices since 1995 in sales leadership positions within service and device organizations. He joined EndoChoice in early 2008 and is responsible for driving revenues via the U.S. sales organization. He also leads the sales training and operations organization plus national and corporate accounts.
Prior to EndoChoice, Mr. Costantino served as Manager of Market Development for Boston Scientific Endoscopy. From 2004 to 2008, Mr. Costantino held a variety of leadership positions in Sales, Training, and Marketing. During that time, he won a number of sales awards, including the President's Club award in 2005 and 2006, which honors the top performers within the sales organization.
From 1995 to 2004, Mr. Costantino held a variety of positions with Factory Authorized Medical Scope Repair, including Territory Manager, Eastern Area Sales Manager, Director of Sales and Operations and Vice President of Sales.
Mr. Costantino holds a B.A. from Harvard University.
Kristen Schuller has over 20 years of global human resources management and consulting experience within both privately and publicly traded enterprises. She joined EndoChoice in early 2013. At EndoChoice, Ms. Schuller’s responsibilities include the design and development of global human resources strategies and the delivery of programs and services that drive the company’s objectives, support the diverse workforce and foster our unique culture. Key worldwide activities include talent acquisition, organizational design, performance and development, compensation and benefits, employee relations and employee communications.
From 2007 to 2013, Ms. Schuller led the Global Human Resources organization as Director for AJC International, Inc., a $1.5 billion global marketer of commodity protein products, logistics and distribution services. As a member of the senior leadership team, Ms. Schuller lead the strategic direction and execution of talent initiatives, including leadership continuity and development, talent acquisition and retention, organizational design and total rewards.
Before joining AJC International, Ms. Schuller served in senior human resources management and consulting roles for The Coca-Cola Company and Ernst & Young LLP from 1999 to 2007. She lead one of the largest global human capital engagements in the firm’s history. Prior to her work at these premier organizations, Ms. Schuller served as the Manager of International Compensation for AlliedSignal (now Honeywell), providing human resources support through Six Sigma methodologies to accelerate the growth of its global workforce in the aerospace, automotive and engineered materials industry. Ms. Schuller began her career in international human resources, working in the consumer foods industry for the Latin American division of CPC International (later acquired by Unilever) from 1991 to 1996.
Ms. Schuller holds a B.A. in Hispanic Language & Literature and International Relations from Boston University and obtained her Master’s degree in Human Resources Management from Seton Hall University.
GB Pratt has worked in the field of GI services and healthcare IT since 1996 in sales and operational leadership roles. He joined EndoChoice in 2008 and is responsible for Technology Enabled Services which includes diagnostics, scope services and customer care. All three service units have similar operational demands and frequent, almost daily, interactions with our customers. Mr. Pratt ensures the team provides world-class support in our mission to serve the GI caregiver.
Prior to EndoChoice, Mr. Pratt served in a variety of management positions within the healthcare IT space. Mr. Pratt was the co-founder and CEO of VLink, a healthcare integration platform that linked hospitals with physician electronic medical records (EMR’s). VLink was sold in 2008 to Portico Systems, a partner company of Safeguard Scientifics (NYSE: SFE). From 2002 to 2006 he held several roles, including Vice President of Sales for eko systems, a provider of hospital-based EMR’s for the perioperative space.
From 1996 to 2002, Mr. Pratt held several positions with Factory Authorized Medical Scope Repair including Territory Manager, Regional Manager and Eastern Area Sales Manager.
Mr. Pratt holds a B.Sc. in Marketing from Pennsylvania State University.
Yaniv Kirma has more than 15 years of high-tech industry experience and has a strong track record of innovation in optics, video and image processing. He co-founded Peer Medical in 2010, which is the foundation for the EndoChoice imaging division. At EndoChoice, Mr. Kirma’s is responsible for leading the EndoChoice Innovation Center to create revolutionary technologies to serve the GI professional and developing products with a competitive edge allowing the company to successfully compete in the market.
Mr. Kirma has led successful teams in the defense and medical device markets. In 2007, he joined Stryker, which was developing a fully disposable colonoscope. Mr. Kirma served as the R&D Project Manager and Electronic Team Leader for this project. From 1998-2007, Mr. Kirma held a variety of positions at Elbit Systems LTD. He led development groups in the defense industry that designed displays and mission computers for fighters, and control systems for civil airplanes. In this role, Mr. Kirma worked closely with large aerospace and defense companies, like Boeing and Lockheed Martin.
Mr. Kirma holds a B.Sc. in Electrical Engineering and Physics from the Technion – Israel Institute of Technology.
Brit Young joined EndoChoice in early 2008 as General Counsel & Director of Business Development and leads the company’s global legal, intellectual property, and M&A activities, as well as supports new business development efforts, including strategic partnerships and licensing opportunities.
Mr. Young was first introduced to EndoChoice in 2007 while in the corporate transactions group at Womble Carlyle Sandridge & Rice, a leading corporate law firm. He served as EndoChoice’s first outside counsel and worked with Mark Gilreath and Will Parks to incorporate the company and secure its initial rounds of financing. During his tenure in private practice, Mr. Young worked with a wide variety of high-growth companies helping them manage complex transactions such as mergers, acquisitions, partnerships and venture financings.
Mr. Young earned his bachelor’s degree in finance, MBA and JD from the University of Florida.
US: 888.682.ENDO (3636)Intl: +49 (0) 4101 5173-0